Tampa, FL–Robert Rothman has been appointed the next chairman of the Moffitt Cancer Center Board of Directors. Sen. Connie Mack, the immediate past chairman, will remain on the Board as Chair Emeritus and will continue to be actively involved at the cancer center. Sen. Mack will be forming an advisory board for the Donald A. Adam Comprehensive Melanoma Research Center.
“We are very grateful for the leadership and total investment that Sen. Mack has made to Moffitt and its mission, and I am extremely appreciative for what he has done and will do for our cause,” said Dr. William S. Dalton, CEO and center director of Moffitt. “It’s an exciting time for the cancer center, and I look forward to working with Bob in the planning of our future.”
Rothman is the chairman of the Board of Florida Bank Group Inc., a multibank holding company headquartered in Tampa. He is also CEO of Black Diamond Group, which was formed in 1999 as a private investment firm. He was chairman and CEO of Consolidated International Group Inc., which owned and operated insurance companies in Europe and North America from 1987 to 1999. Prior to founding the Consolidated Group of companies in 1987, he was executive vice president and chief financial officer of Beneficial Insurance Group. Rothman also worked for Charter Security Life Insurance Company as senior vice president and treasurer and began his career with Ernst & Young in New York in 1977.
Rothman obtained an MBA in finance from The University of Chicago Graduate School of Business, and a B.A. in economics from Queens College in New York. He is co-owner and board member of the Washington Redskins NFL franchise; board member and chair of the Audit Committee of Cbeyond Corporation in Atlanta; member of the Advisory Council for Chicago’s Graduate School of Business. He previously served as trustee and board chair for the Academy of the Holy Names, Tampa, and director of the University of Tampa.
Sen. Mack has achieved many accomplishments during his seven-year tenure as chairman, including: Moffitt designation as an NCI Comprehensive Cancer Center in 2001; appointment of Dalton as Center Director; opening of the Vincent A. Stabile Research Building and Moffitt clinic expansion; creation of Moffitt’s National Board of Advisors, chaired by Sam Donaldson; establishment of the McGillicuddy Endowed Chair for Melanoma Research and Treatment; expansion of Moffitt’s commercialization and technology efforts through creation of Moffitt Technologies Corporation; development of Moffitt’s Total Cancer Care model; and the successful revision to the Moffitt-USF business model and establishment of the Moffitt Medical Group
Some of the cancer center’s most illustrious partnerships were executed under Mack’s leadership, including the collaboration with Merck and the formation of M2Gen, Moffitt’s wholly owned biotechnology subsidiary and the partnership between Shands HealthCare and the University of Florida to improve cancer care for residents in Florida. The cancer center also received its largest single gift of $20.4 million from philanthropist Donald A. Adam to develop the Comprehensive Melanoma Research Center.
The role of Moffitt’s Parent Board is to serve as parent of the system and oversee the affairs of the subsidiaries. As such, board members establish the systemwide mission, strategic plan, operational and financial standards and other policies, and otherwise coordinate system affairs through the exercise of reserved powers. The parent corporation conducts research activities of the system.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center (www.moffitt.org) is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer as well as for ear, nose and throat. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.